Analysts: Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

16.53USD
1 Aug 2013
Price Change (% chg)

$-0.73 (-4.23%)
Prev Close
$17.26
Open
$16.78
Day's High
$16.95
Day's Low
$16.48
Volume
233,326
Avg. Vol
137,075
52-wk High
$18.02
52-wk Low
$10.05

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.46 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 3 2 2
(2) OUTPERFORM 1 1 0 0
(3) HOLD 1 2 3 3
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 2.14 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 6 8.59 12.00 6.91 --
Quarter Ending Dec-13 6 8.40 11.00 6.90 --
Year Ending Dec-13 7 32.81 42.60 28.75 67.50
Year Ending Dec-14 7 145.75 289.00 18.99 66.09
Earnings (per share)
Quarter Ending Sep-13 7 -0.46 -0.43 -0.55 --
Quarter Ending Dec-13 7 -0.46 -0.39 -0.57 --
Year Ending Dec-13 8 -1.88 -1.73 -2.10 -0.94
Year Ending Dec-14 7 -0.03 3.28 -2.28 -1.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 9.69 7.60 2.08 21.51
Quarter Ending Dec-12 10.41 12.73 2.32 22.25
Quarter Ending Sep-12 16.48 5.10 11.37 69.04
Quarter Ending Jun-12 18.99 21.86 2.87 15.11
Quarter Ending Mar-12 40.51 24.23 16.28 40.19

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 8.59 8.65 8.81 9.12 --
Quarter Ending Dec-13 8.40 8.46 8.63 8.90 --
Year Ending Dec-13 32.81 32.53 32.96 33.56 67.50
Year Ending Dec-14 145.75 55.75 56.18 56.35 66.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 1 0 2
Quarter Ending Dec-13 0 1 0 2
Year Ending Dec-13 1 0 1 1
Year Ending Dec-14 4 0 4 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks